Moderna Says Pfizer COVID Vax Patent Challenges Fail Fintiv
Moderna has urged the Patent Trial and Appeal Board not to review its COVID-19 vaccine patents challenged by rivals Pfizer and BioNTech, saying a related district court trial will likely end...To view the full article, register now.
Already a subscriber? Click here to view full article